Annie Gardner
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Psoriasis: Treatment and Pathogenesis 3
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Huaming Tan (3 shared papers)John S. Bradley (2 shared papers)Paul Newell (2 shared papers)Dalia Wajsbrot (2 shared papers)Gregory G. Stone (2 shared papers)Katrina Yates (2 shared papers)Karen Cheng (2 shared papers)Margaret Tawadrous (2 shared papers)
- Journals
- Open Forum Infectious Diseases (2 papers)Journal of the American Academy of Dermatology (2 papers)The Pediatric Infectious Disease Journal (2 papers)The Lancet Infectious Diseases (1 paper)British Journal of Dermatology (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Annie Gardner
9 papers receiving 330 citations
Peers
Comparison fields: 5 of 52
- Molecular Medicine 71
- Applied Microbiology and Biotechnology 16
- Rheumatology 72
- Dermatology 40
- Immunology 98
Countries citing papers authored by Annie Gardner
This map shows the geographic impact of Annie Gardner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Gardner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Gardner more than expected).
Fields of papers citing papers by Annie Gardner
This network shows the impact of papers produced by Annie Gardner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Gardner. The network helps show where Annie Gardner may publish in the future.
Co-authors
The 25 scholars most cited alongside Annie Gardner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 126 | |
| 2 | 2019 | 57 | |
| 3 | 2019 | 51 | |
| 4 | 2018 | 49 | |
| 5 | 2018 | 26 | |
| 6 | 2025 | 7 | |
| 7 | 2022 | 6 | |
| 8 | 2024 | 6 | |
| 9 | 2022 | 5 |
About Annie Gardner
Annie Gardner is a scholar working on Immunology, Infectious Diseases, Pediatrics, Perinatology and Child Health, Epidemiology and Emergency Medicine, having authored 9 papers that have together received 333 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (3 papers), COVID-19 Clinical Research Studies (1 paper), Appendicitis Diagnosis and Management (1 paper), Pediatric Urology and Nephrology Studies (1 paper), Respiratory viral infections research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Molecular Medicine (71 citations), Applied Microbiology and Biotechnology (16 citations), Rheumatology (72 citations), Dermatology (40 citations) and Immunology (98 citations). Annie Gardner has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Huaming Tan, John S. Bradley, Paul Newell, Dalia Wajsbrot, Gregory G. Stone, Katrina Yates, Karen Cheng, Margaret Tawadrous, Helen Broadhurst and Svitlana Tatulych. Their work appears in journals such as Open Forum Infectious Diseases, Journal of the American Academy of Dermatology, The Pediatric Infectious Disease Journal, The Lancet Infectious Diseases and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.